Drug Database
Back to search

Finland· FI-REL-REL47397

Zavicefta

A ceftazidim und beta-lactamase-inhibitor product containing ceftazidime pentahydrate + avibactam sodium, registered in Finland by Pfizer Ireland Pharmaceuticals Unlimited Company. The same ATC class is registered in 10 of our 19 countries.

ATC J01DD52

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedZaviceftaATCJ01DD52REGISTER NO.FI-REL-REL47397PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ceftazidime pentahydrate + avibactam sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ceftazidim und beta-lactamase-inhibitor is registered in 10 of 19 countries.

Countries holding a registration under ATC J01DD52 (ceftazidim und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose
Search ceftazidim und beta-lactamase-inhibitor products by name

Ceftazidim und beta-lactamase-inhibitor · ATC J01DD52

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ceftazidim und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ceftazidim und beta-lactamase-inhibitor · price per daily dose (6 g)

USD · FX 28 Sept 2026

  • CH Switzerland$407.92
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Ceftazidime pentahydrate + Avibactam sodium
Manufacturer
Pfizer Ireland Pharmaceuticals Unlimited Company
Country
Finland (FI)
ATC code
J01DD52
ATC class
Ceftazidim und Beta-Lactamase-Inhibitor
Defined daily dose
6 g, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    408566
    10 x (2 g / 0.5 g)
    EUR 1454.07

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ceftazidim und beta-lactamase-inhibitor in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftazidim und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Zavicefta
  • Liechtenstein · Zavicefta
  • Norway · Zavicefta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/747d45eb-aa6c-4dcd-b6f3-76cf4a06dec4
GET /v1/drugs/747d45eb-aa6c-4dcd-b6f3-76cf4a06dec4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "6",
  "form": "kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos",
  "route": "Laskimoon",
  "ddd_unit": "g",
  "strength": "2 g / 0.5 g",
  "atc_label": "keftatsidiimi ja beetalaktamaasin estäjä",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/16/1109/001",
  "fimea_rel_id": "REL47397",
  "authorised_at": "2016-06-24"
}
API referenceMCP serverPlans

See everything about ceftazidim und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console